2000
Innovative, New System Represents Guidant''s Eighth Major Product Approval in Four Months. Market Anticipation of New Coronary Stent Impacts Third Quarter Revenues Indianapolis, Ind. and Santa...
National Institute for Clinical Excellence Recommends Three-Fold Increase in Defibrillator Use Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary and peripheral vascular disease, today announced the start of a clinical trial to determine...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Guidant president and CEO Ron Dollens has been named to the board of directors of the Alliance for Aging Research....
Company to Make Acquisition Decision After Completing Comprehensive Investigation Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry,...
Screening for Abdominal Aortic Aneurysm Also Available in Select Sites for the First Time Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
World''s Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implants of...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received U.S. Food and...
Study Examines Alternative Treatment for Hypertension Caused by Renal Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Patients suffering from high blood pressure caused by renal artery...
Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study show that a new procedure utilizing endoscopic vein harvesting leads to fewer wound healing complications compared to...